# A Pharmacokinetic Study of SHR8554 Injection in the Population With Renal Insufficiency and Healthy Participants

> **NCT07189962** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Moderate to Severe Postoperative Pain

## Interventions

- **DRUG:** SHR8554 Injection

## Key facts

- **NCT ID:** NCT07189962
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-20
- **Primary completion:** 2023-04-13
- **Final completion:** 2023-04-13
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07189962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07189962, "A Pharmacokinetic Study of SHR8554 Injection in the Population With Renal Insufficiency and Healthy Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07189962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*